pyrroles has been researched along with Parasitemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Briolant, S; Desgrouas, C; Dormoi, J; Pradines, B | 1 |
| Li, Q; Lin, AJ; Skillman, DS; Smith, K; Xie, LH; Zhang, J | 1 |
| Ang, KK; Holmes, MJ; Kara, UA | 1 |
3 other study(ies) available for pyrroles and Parasitemia
| Article | Year |
|---|---|
Impact of methylene blue and atorvastatin combination therapy on the apparition of cerebral malaria in a murine model.
Topics: Animals; Antimalarials; Atorvastatin; Disease Models, Animal; Drug Synergism; Female; Heptanoic Acids; Kaplan-Meier Estimate; Malaria, Cerebral; Methylene Blue; Mice; Mice, Inbred C57BL; Parasitemia; Pyrroles | 2013 |
New potential antimalarial agents: therapeutic-index evaluation of pyrroloquinazolinediamine and its prodrugs in a rat model of severe malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Malaria; Maximum Tolerated Dose; Parasitemia; Plasmodium berghei; Prodrugs; Pyrroles; Quinazolines; Random Allocation; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Therapeutic Equivalency | 2006 |
Immune-mediated parasite clearance in mice infected with Plasmodium berghei following treatment with manzamine A.
Topics: Animals; Antibodies, Protozoan; Antimalarials; Carbazoles; Cytokines; Erythrocytes; Immunoglobulin G; Indoles; Malaria; Male; Mice; Parasitemia; Plasmodium berghei; Pyrroles | 2001 |